ArticleActa neuropathologica communications2014

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.

Heidi Vn Küsters-Vandevelde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.